Monday, March 3, 2014
The National Law Journal Names Labaton Sucharow Top Plaintiffs' Firm for the Ninth Straight YearNEW YORK (March 3, 2014) — Labaton Sucharow LLP announced today that it was named to The National Law Journal's annual Plaintiffs' Hot List, marking the ninth consecutive year of recognition as a top plaintiffs firm. This year, only 12 firms were selected to the list based off of notable verdicts or settlements over the past year.
Labaton Sucharow is featured for its securities fraud litigation work on several cases, including a class action against pharmaceutical company Schering-Plough Corp. (which later merged with Merck & Co.), achieving a recovery of $473 million for investors, as well as prosecuting a complex securities case against American International Group Inc., resulting in a recovery of more than $1 billion in settlements.
The National Law Journal also asked winning firms for trial tips. Labaton Sucharow partners Thomas Dubbs and Christopher McDonald offered the following:
- Incorporate credible portions of the other side's narrative into your own argument.
- When involved in a pharmaceutical, biotech or medical device lawsuit, you must understand the science; you cannot get through depositions otherwise.
- In securities cases, many jurors believe the stock market is a crapshoot, so it's necessary to explain how their pensions are often based on equity investments.
The full profile on the Firm can be found here.